SCHEMBL6216630

SCHEMBL6216630

N#Cc1cc[nH]c1NCCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 6/20 0.42
TAAR1 Q96RJ0 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 4/20 0.41
TSHR P16473 3/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41
NPC1 O15118 2/20 0.41
LMNA P02545 2/20 0.41
RAB9A P51151 2/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAOA P21397 3/20 0.39
MAOB P27338 3/20 0.39
CCNC P24863 2/20 0.39
CDK8 P49336 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22784143 0.73 CCNC (0.51) L3MBTL1ALDH1A1TAAR1SMN1; SMN2KDM4E
SCHEMBL27851103 0.68 KDM4E (0.40) ALDH1A1TAAR1SMN1; SMN2KDM4ETSHR
SCHEMBL6965186 0.68 KDM4E (0.47) L3MBTL1ALDH1A1TAAR1SMN1; SMN2KDM4E
SCHEMBL3288225 0.68 NPC1 (0.63) L3MBTL1ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL1780240 0.66 MCL1 (0.46) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL22784145 0.65 ALDH1A1 (0.57) L3MBTL1ALDH1A1TAAR1SMN1; SMN2KDM4E
SCHEMBL2243709 0.64 NPC1 (0.52) L3MBTL1ALDH1A1TAAR1SMN1; SMN2KDM4E
SCHEMBL8557281 0.64 L3MBTL1 (0.53) L3MBTL1ALDH1A1TAAR1SMN1; SMN2KDM4E
SCHEMBL17554284 0.64 ELANE (0.51) L3MBTL1TAAR1SMN1; SMN2KDM4EPKM
SCHEMBL20494780 0.64 HDAC3 (0.55) L3MBTL1ALDH1A1TAAR1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1450811-A4 2-ARYL PYRROLOPYRIMIDINES FOR A1 AND A3 RECEPTORS OSI PHARM INC (US) 2005-11-16 EP disclosed
EP-1347980-A4 COMPOUNDS SPECIFIC TO ADENOSINE-A1,-A2A, AND- A3-RECEPTOR AND USES THEREOF OSI PHARM INC (US) 2005-02-09 EP disclosed
EP-1450811-A2 2-ARYL PYRROLOPYRIMIDINES FOR A1 AND A3 RECEPTORS Osi Pharmaceuticals, Inc. (US) 2004-09-01 EP disclosed
EP-1347980-A1 COMPOUNDS SPECIFIC TO ADENOSINE-A1,-A2A, AND- A3-RECEPTOR AND USES THEREOF OSI Pharmaceuticals, Inc. (US) 2003-10-01 EP disclosed
WO-2003048120-A2 2-ARYL PYRROLOGPYRIMIDINES FOR A1 AND A3 RECEPTORS OSI PHARMACEUTICALS, INC. (US) 2003-06-12 WO disclosed
WO-2002057267-A1 COMPOUNDS SPECIFIC TO ADENOSINE A1, A2A, AND A3 RECEPTOR AND USES THEREOF OSI PHARMACEUTICALS, INC. (US) 2002-07-25 WO disclosed